Detalhe da pesquisa
1.
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2+ breast cancer.
bioRxiv
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352476
2.
A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
Clin Exp Metastasis
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717519
3.
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.
Nat Cancer
; 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355777
4.
Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer.
Cancer Discov
; 13(6): 1428-1453, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36946782
5.
Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.
Oncogene
; 41(28): 3640-3654, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701533
6.
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment.
Cancer Immunol Res
; 10(5): 656-669, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201318
7.
A T-rojan horse strategy for cancer immunotherapy.
Sci Immunol
; 6(59)2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963062
8.
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844).
Clin Cancer Res
; 27(21): 5828-5837, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135021
9.
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide.
Oncoimmunology
; 9(1): 1760685, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923118
10.
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.
Cancer Immunol Res
; 6(12): 1561-1577, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341213